116 related articles for article (PubMed ID: 1756515)
1. Levels of the adducts of 4-aminobiphenyl to hemoglobin in control subjects and bladder carcinoma patients.
Del Santo P; Moneti G; Salvadori M; Saltutti C; Delle Rose A; Dolara P
Cancer Lett; 1991 Dec; 60(3):245-51. PubMed ID: 1756515
[TBL] [Abstract][Full Text] [Related]
2. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
3. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.
Tao L; Day BW; Hu B; Xiang YB; Wang R; Stern MC; Gago-Dominguez M; Cortessis VK; Conti DV; Van Den Berg D; Pike MC; Gao YT; Yu MC; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):937-45. PubMed ID: 23539508
[TBL] [Abstract][Full Text] [Related]
4. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
[TBL] [Abstract][Full Text] [Related]
6. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
Bartsch H; Caporaso N; Coda M; Kadlubar F; Malaveille C; Skipper P; Talaska G; Tannenbaum SR; Vineis P
J Natl Cancer Inst; 1990 Dec; 82(23):1826-31. PubMed ID: 2250298
[TBL] [Abstract][Full Text] [Related]
7. Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients.
Zayas B; Stillwell SW; Wishnok JS; Trudel LJ; Skipper P; Yu MC; Tannenbaum SR; Wogan GN
Carcinogenesis; 2007 Feb; 28(2):342-9. PubMed ID: 16926175
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography- tandem mass spectrometry.
Seyler TH; Reyes LR; Bernert JT
J Anal Toxicol; 2010; 34(6):304-11. PubMed ID: 20663282
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
10. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
11. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
[TBL] [Abstract][Full Text] [Related]
12. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers.
Perera FP; Santella RM; Brenner D; Poirier MC; Munshi AA; Fischman HK; Van Ryzin J
J Natl Cancer Inst; 1987 Sep; 79(3):449-56. PubMed ID: 3114532
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
[TBL] [Abstract][Full Text] [Related]
14. Urine markers for bladder cancer surveillance: a systematic review.
Ratliff TL
J Urol; 2005 Nov; 174(5):2065-6. PubMed ID: 16217395
[No Abstract] [Full Text] [Related]
15. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry.
Lin D; Lay JO; Bryant MS; Malaveille C; Friesen M; Bartsch H; Lang NP; Kadlubar FF
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):11-6. PubMed ID: 7889831
[TBL] [Abstract][Full Text] [Related]
16. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
18. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
Poirier MC; Beland FA
Mutat Res; 1997 May; 376(1-2):177-84. PubMed ID: 9202754
[TBL] [Abstract][Full Text] [Related]
19. Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.
Tai CJ; Liao CF; Su TC; Shen KH; Chang CC; Lin SH; Yeh CM; Shen SC; Lee WR; Chiou JF; Lin CH; Chen YC; Shih HY; Yeh KT; Jiang MC
Int J Biol Markers; 2012 Oct; 27(3):e280-4. PubMed ID: 22653741
[TBL] [Abstract][Full Text] [Related]
20. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies.
Airoldi L; Orsi F; Magagnotti C; Coda R; Randone D; Casetta G; Peluso M; Hautefeuille A; Malaveille C; Vineis P
Carcinogenesis; 2002 May; 23(5):861-6. PubMed ID: 12016161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]